Properties (87)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:Kirin_Holdings_Company
Kirin_Pharmaceutical |
| gptkbp:CEO |
Gyo_Sagara
|
| gptkbp:clinicalTrials |
Phase 2 trials for Eylea
Phase 3 trials for Opdivo |
| gptkbp:collaborations |
gptkb:Yale_University
gptkb:University_of_Tokyo |
| gptkbp:employees |
approximately 1,500
|
| gptkbp:established |
as a drug manufacturer
|
| gptkbp:founded |
1717
|
| gptkbp:headquarters |
gptkb:Osaka,_Japan
|
| https://www.w3.org/2000/01/rdf-schema#label |
Ono Pharmaceutical
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:partnerships |
gptkb:Celgene_Corporation
gptkb:Sanofi_S.A. gptkb:AstraZeneca gptkb:Johnson_&_Johnson gptkb:Takeda_Pharmaceutical_Company gptkb:Boehringer_Ingelheim gptkb:Bristol-Myers_Squibb gptkb:Eisai_Co.,_Ltd. gptkb:Pfizer gptkb:Regeneron_Pharmaceuticals gptkb:Mylan_N.V. gptkb:Merck_&_Co. gptkb:Regeneron_Pharmaceuticals,_Inc. gptkb:Roche gptkb:Gilead_Sciences,_Inc. gptkb:Amgen_Inc. gptkb:Bristol-Myers_Squibb_Company gptkb:Amgen gptkb:AbbVie_Inc. gptkb:Gilead_Sciences gptkb:Sandoz gptkb:Hikma_Pharmaceuticals Novartis Sanofi AbbVie Merck KGaA Aurobindo Pharma. Biocon. Cadila Healthcare. Torrent Pharmaceuticals. Zydus Cadila. AstraZeneca_PLC. Johnson_&_Johnson. Novartis_AG. Roche_Holding_AG. Takeda_Pharmaceutical_Company_Limited. Alkem_Laboratories. Alkem_Laboratories_Limited. Aurobindo_Pharma_Limited. Biocon_Limited. Boehringer_Ingelheim_GmbH. Cadila_Healthcare_Limited. Celgene_Corporation. Dr._Reddy's_Laboratories. Dr._Reddy's_Laboratories_Limited. Hikma_Pharmaceuticals_PLC. Intas_Pharmaceuticals. Intas_Pharmaceuticals_Limited. Lupin_Pharmaceuticals. Lupin_Pharmaceuticals_Limited. Merck_KGaA. Sandoz_International_GmbH. Sun_Pharmaceutical_Industries. Sun_Pharmaceutical_Industries_Limited. Torrent_Pharmaceuticals_Limited. Wockhardt. Wockhardt_Limited. |
| gptkbp:products |
gptkb:Lonsurf
gptkb:Opdivo gptkb:Eylea |
| gptkbp:research |
Dr._Masahiro_Tada
|
| gptkbp:research_areas |
autoimmune diseases
neurological disorders cardiovascular diseases infectious diseases |
| gptkbp:research_focus |
oncology
immunology |
| gptkbp:revenue |
$1.5 billion (2020)
|
| gptkbp:stockExchange |
gptkb:Tokyo_Stock_Exchange
4528 |
| gptkbp:subsidiary |
Ono Pharmaceutical USA, Inc.
Ono_Pharmaceutical_Europe_Ltd. |
| gptkbp:website |
www.ono.co.jp
|